Serum sRAGE as a Potential Biomarker for Pediatric Bronchiolitis: A Pilot Study

Lung

Volumn 193, Issue 1, 2015, Pages 19-23

  García Salido, Alberto ^a   Oñoro, Gonzalo ^a   Melen, Gustavo J ^a   Gómez Piña, Vanesa ^a   Serrano González, Ana ^a   Ramírez Orellana, Manuel ^a   Casado Flores, Juan ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Bronchiolitis; Critical care medicine; Soluble receptor for advanced glycation end product

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; GAMMA INTERFERON; PROCALCITONIN; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BIOLOGICAL MARKER; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; NEUTROPHIL; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; OXYGEN NASAL CANNULA; OXYGEN THERAPY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; AGE; BLOOD; CASE CONTROL STUDY; FEMALE; HOSPITAL ADMISSION; INFANT; LENGTH OF STAY; MALE; NEWBORN; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TIME; UPREGULATION;

AGE FACTORS; BIOLOGICAL MARKERS; BRONCHIOLITIS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; PATIENT ADMISSION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UP-REGULATION;

EID: 84938097483     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-014-9663-9     Document Type: Article

References (25)

1. Mansbach JM, Piedra PA, Stevenson MD et al (2012) Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics 130:e492–e500
2. Ochoa Sangrador C, Gonzalez de Dios J, Research Group of the aBREVIADo Project (2012) Management of acute bronchiolitis in emergency wards in Spain: variability and appropriateness analysis (aBREVIADo Project). Eur J Pediatr 171:1109–1119
3. Kawasaki Y, Endo K, Suyama K et al (2011) Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatr Pulmonol 46:18–22
4. Ricart S, Marcos MA, Sarda M et al (2012) Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity. Pediatr Pulmonol. doi:10.1002/ppul.22633
5. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 162:210–215
6. Neeper M, Schmidt AM, Brett J et al (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998–15004
7. Yerkovich ST, Chang AB, Carroll ML et al (2012) Soluble receptor for advanced glycation end products (sRAGE) is present at high concentrations in the lungs of children and varies with age and the pattern of lung inflammation. Respirology 17:841–846
8. Buckley ST, Ehrhardt C (2010) The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010:917108
9. Yan SF, Ramasamy R, Schmidt AM (2010) Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 79:1379–1386
10. Santilli F, Vazzana N, Bucciarelli LG et al (2009) Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 16:940–952
11. Ramasamy R, Yan SF, Schmidt AM (2009) RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts. J Leukoc Biol 86:505–512
12. Gonzalez I, Romero J, Rodriguez BL et al (2013) The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology 218:790–797
13. Hergrueter AH, Nguyen K, Owen CA (2011) Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. Am J Physiol 300:L512–L515
14. Drinda S, Franke S, Eidner T et al (2009) Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Clin Exp Rheumatol 27:483–490
15. Dettoraki A, Gil AP, Spiliotis BE (2009) Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 22:895–904
16. Frommhold D, Kamphues A, Dannenberg S et al (2011) RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner. BMC Immunol 12:56
17. Agostoni P, Banfi C, Magri D et al (2011) Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery. Respir Physiol Neurobiol 178:256–260
18. Guo C, Zeng X, Song J et al (2012) A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway. Int J Mol Sci 13:11923–11940
19. Griffiths MJ, McAuley DF (2008) RAGE: a biomarker for acute lung injury. Thorax 63:1034–1036
20. Chen Y, Akirav EM, Chen W et al (2008) RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 181:4272–4278
21. Bopp C, Hofer S, Weitz J et al (2008) sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 147:79–83
22. Jabaudon M, Futier E, Roszyk L et al (2011) Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 39:480–488
23. Kneyber MC, Gazendam RP, Niessen HW et al (2009) Mechanical ventilation during experimental sepsis increases deposition of advanced glycation end products and myocardial inflammation. Crit Care 13:R87
24. Calfee CS, Budev MM, Matthay MA et al (2007) Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transpl 26:675–680
25. Mauri T, Masson S, Pradella A et al (2010) Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med 222:105–112